Specificity of Effector Mechanisms in Syngeneic Graft-vs-Host Disease: Recognition of the MHC Class II Invariant Chain Peptide (CLIP)

By Hess A.   Thoburn C.   Bright E.   Horwitz L.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 725-727

Elsevier

Access to resources Recommend Favorite

An altered invariant chain protein with an antigenic peptide in place of CLIP forms SDS-stable complexes with class II αβ dimers and facilitates highly efficient peptide loading

By Barton G.   Rudensky A.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1159-1165

Oxford University Press

Access to resources Recommend Favorite

The MHC class II  chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal

By Khalil H.  

International Immunology, Vol. 15, Iss. 10, 2003-10 ,pp. : 1249-1263

Oxford University Press

Access to resources Recommend Favorite

Phosphorylation of class II transactivator regulates its interaction ability and transactivation function

By Sisk T.J.  

International Immunology, Vol. 15, Iss. 10, 2003-10 ,pp. : 1195-1205

Oxford University Press

Access to resources Recommend Favorite

The N-Terminal Flanking Region of the Invariant Chain Peptide Augments the Immunogenicity of a Cryptic “Self” Epitope from a Tumor-Associated Antigen

By Hess A.D.   Thoburn C.   Chen W.   Miura Y.   van der Wall E.  

Clinical Immunology, Vol. 101, Iss. 1, 2001-10 ,pp. : 67-76

Academic Press

Access to resources Recommend Favorite